Makers Laboratories Ltd. Share Price & Stock Analysis

Makers Laboratories Ltd. (BSE: 506919) is a Mumbai, Maharashtra-based company in the Pharmaceuticals industry. With a market capitalisation of ₹187 Cr, it ranks #2,712 by market cap among the 6,197 Indian listed companies on FinBizNet, and #37 of 63 in Pharmaceuticals. At ₹301.08 (as of 16 Nov 2026), the share price is 10.1% below its 52-week high of ₹335.00 and 100.7% above its 52-week low of ₹150.00. The share price is up 27.7% over one year and up 24.6% over three months.

Key Metrics

Current Price₹301.08
Market Cap₹187 Cr
BSE Code506919
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Pharmaceuticals
P/E Ratio79.2
Return on Equity9.94%
Return on Assets4.15%
52-Week Range₹150.00 – ₹335.00
1-Year Price Change+27.7%
3-Month Price Change+24.6%
Beta (1Y)0.2
Dividend Yield0.00%
HeadquartersMumbai, Maharashtra
Websitewww.makerslabs.com

Shareholding and Delivery

Delivery averaged 64.5% of traded volume across 15 NSE sessions (22 Oct 2026 – 12 Nov 2026).

About Makers Laboratories Ltd.

Makers Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations in India. It operates in two segments, Pharmaceutical and Chemical Manufacturing. The company offers general health therapeutic products, including acid regulatory, anthelmintic, anti-allergic, anti-asthmatic, anti-biotic, anti-diabetics, anti-diarrhoeals, anti-emetics and anti-nauseants, anti-fungal, anti-hypertensive, anti–inflammatory, analgesic, anti-spasmodic, anti-malarial, and anti-thyroid. It also provides cough and cold control, digestives, neurotonics, nutritional supplements, topical anti-biotic/anti-microbial, and other specialty drugs. The company sells its products under the Duramol, Artemak-AB, Loroquin, Nimuwin, Coffwin, and Exylin brands. It distributes its products through agents, stockiest, doctors, and retailers. The company was incorporated in 1984 and is based in Mumbai, India.

Products and Services

1. Pharmaceutical-This segment offers pharmaceutical products. 2. Chemical Manufacturing-This segment engages in the chemical manufacturing business. 3. Segment Adjustment-0

Business Segments

1. Pharmaceutical-35.8% 2. Chemical Manufacturing-64.2%

Makers Laboratories Ltd. vs Peers — Pharmaceuticals

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Abbott India Ltd.₹56,531 Cr36.334.46%₹1,814 Cr-8.1%
Emcure Pharmaceuticals Ltd₹42,344 Cr47.919.57%₹2,820 Cr+73.3%
Ajanta Pharma Limited₹41,474 Cr39.425.39%₹1,794 Cr+27.8%
Piramal Pharma Ltd₹32,600 Crn/m-4.00%₹2,617 Cr+22.8%
RUBICON RESEARCH LIMITED₹28,526 Cr112.319.14%₹576 Cr+162.7%
Caplin Point Laboratories Ltdte₹18,155 Cr28.319.94%₹630 Cr+23.6%
Pfizer Ltd.₹17,811 Cr24.517.16%₹727 Cr-24.2%
Eris Lifesciences Ltd₹17,691 Cr28.318.07%₹892 Cr-17.5%
Makers Laboratories Ltd.₹187 Cr79.29.94%—+27.7%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Makers Laboratories Ltd.?

Makers Laboratories Ltd. is trading at ₹301.08, with a market capitalisation of ₹187 Cr.

Which sector does Makers Laboratories Ltd. belong to?

Makers Laboratories Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Pharmaceuticals).

What are the key financial ratios of Makers Laboratories Ltd.?

Makers Laboratories Ltd. has a P/E of 79.2 and a return on equity of 9.94%.

What is the stock symbol of Makers Laboratories Ltd.?

Makers Laboratories Ltd. is listed on the BSE under the scrip code 506919.

How has Makers Laboratories Ltd.'s share price moved over the past year?

Makers Laboratories Ltd.'s share price is up 27.7% over one year and up 24.6% over three months. Its 52-week range is ₹150.00 to ₹335.00.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.